Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-06-01

Clinical Trial Update: Onabotulinumtoxin Type A Reconstitution With Preserved Versus Preservative-free Saline in Chronic Migraine. [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating reconstitution of onabotulinumtoxin A with preserved versus preservative-free saline in chronic migraine; results posted after…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Onabotulinumtoxin A (botulinum toxin type A)

Snippet

Sponsor: State University of New York - Upstate Medical University | Conditions: Chronic Migraine, Headache | Phase 4 | Status: COMPLETED | Results posted: 2022-06-01